As a federal crackdown on Ozempic-style copycats looms, Hims is trying a unique new strategy to lobby lawmakers.

Fact checked by Nick Blackmer Compounded versions of semaglutide, the active ingredient in weight loss drugs like Ozempic and ...

A large study adds to evidence that the main ingredient in Novo Nordisk's injectable GLP-1 drug for type 2 diabetes may ...

New research shows GLP1-RA medications do not increase thyroid cancer risk, reassuring users and clinicians. A new study, ...

A Medicine study used artificial intelligence to discover a naturally occurring molecule, specifically, a peptide, that ...

In an interview with 'Self,' influencer Remi Bader opened up about her difficult experience with the weight loss drug Ozempic ...

Semaglutide, the diabetes and weight loss drug that’s commonly known as Ozempic, can help patients of peripheral artery ...

Among patients with diabetes and peripheral artery disease, semaglutide 1 mg increased walking distance vs. placebo, ...

Comedian Nikki Glaser defended those who are taking Ozempic for weight loss and wants people to feel more comfortable talking ...

CHICAGO -- Semaglutide further solidified its efficacy for diabetes-associated cardiovascular conditions, this time building ...

Their project, called Phytogene, harnesses the power of “biopharming” — a method that transforms plants into living drug ...

NanoPortal™ technology successfully delivers semaglutide, the active ingredient in Ozempic®/Wegovy®, in a preclinical study ...